Topic hub

Weight Management

Every current Rare analysis tagged Weight Management, in one place.

43.5% of UK providers that name Wegovy already reference the pill formulation, against 47.8% for the injectable, five weeks…
Latest analysis

Five weeks after launch, the Wegovy pill is named by nearly as many UK providers as the injectable

August 2026 / Obesity / UK

Register to read UK

More analyses

33.4% of open referrals on the NHS community weight-management waiting list have been open more than a year. NHS England…
Blog

The NHS community weight-management list is ageing, not clearing

June 2026 / Obesity / UK

Read now UK
Adult overweight and obesity prevalence spans a 25-point gap across English sub-ICB locations in 2024/25.
Market insights

Obesity in England, where the burden falls

June 2026 / Obesity / UK

Read now UK
Alli leads UK community-pharmacy obesity brand mentions at 68.8% across 2,518 registered pharmacies.
Brand amplification

Brand analysis: UK pharmacy obesity treatments, June 2026

June 2026 / Obesity / UK

Register to read UK

View all 6 analyses →

About this market

This hub collects Rare's market analysis, stats and reports tagged Weight Management across UK private healthcare. It updates automatically as new content is tagged, so it always reflects what's currently published.

Each count is the number of records matching the filter set out in the methodology, read inside one database transaction on its own capture date. Percentages are derived from those counts. Source: Rare.Monitor, market figures read 14 August 2026, platform figures read 4 August 2026.